Share ownership Vertex Pharmaceuticals Incorporated

VRTX

US92532F1003

Pharmaceuticals

Market Closed - Nasdaq 16:00:00 2026-09-15 EDT			5-day change	1st Jan Change
514.63 ^USD	-0.94%		-2.70%	+13.51%

09-14	Vertex Pharmaceuticals Incorporated Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 07:00 AM
09-10	Vertex Pharmaceuticals Incorporated Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference, Sep-10-2026 02:10 PM

Share class: Vertex Pharmaceuticals Incorporated

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	253,460,924	252,924,824 ( 99.79 %)	0	99.79 %

Major shareholders: Vertex Pharmaceuticals Incorporated

Name	Stocks	%	Valuation
Capital Research & Management Co. (World Investors) 10.3 %	26,115,014	10.3 %	14 220 M $
Capital Research & Management Co. (Global Investors) 7.69 %	19,490,637	7.69 %	10 613 M $
BlackRock Advisors LLC 6.928 %	17,558,712	6.928 %	9 561 M $
Vanguard Capital Management LLC 6.542 %	16,580,713	6.542 %	9 029 M $
STATE STREET CORPORATION 4.684 %	11,871,459	4.684 %	6 464 M $
Invesco Advisers, Inc. 3.173 %	8,043,052	3.173 %	4 380 M $
JPMorgan Investment Management, Inc. 2.571 %	6,517,600	2.571 %	3 549 M $
Geode Capital Management LLC 2.374 %	6,017,848	2.374 %	3 277 M $
BlackRock Life Ltd. 2.355 %	5,969,453	2.355 %	3 250 M $
Vanguard Portfolio Management LLC 1.925 %	4,878,987	1.925 %	2 657 M $
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Stocks	%	Valuation
Western Asset Management Company DTVM Ltda. 0.0295 %	299,424	0.0295 %	5 M $
Empiricus Asset Management Ltda. 0.000926 %	9,384	0.000926 %	159 268 $
BRAM - Bradesco Asset Management SA DTVM 0.000562 %	5,696	0.000562 %	96 674 $
XP Allocation Asset Management Ltda. 0.000133 %	1,352	0.000133 %	22 947 $

Breakdown by shareholder type

Institutional	79.08%
Others	11.47%
State Street Corp.	4.68%
Schweizerische Nationalbank	0.28%
Individuals	0.26%
Sumitomo Mitsui Trust Group, Inc.	0.24%
Manulife Financial Corp.	0.22%
Governments	0.14%
Swedbank AB	0.11%
SEI Investments Co.	0.1%
ING Groep NV	0.09%
Danske Bank A/S	0.06%
ABN AMRO Bank NV	0.05%
Fifth Third Bancorp	0.03%
Banco Bilbao Vizcaya Argentaria SA	0.02%
Zurich Insurance Group AG	0.02%
The Bank of Nova Scotia	0.01%
Skandinaviska Enskilda Banken AB	0.01%
The Allstate Corp.	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Silvercrest Asset Management Group, Inc.	0.01%
Unknown	3.09%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	76.59%
United Kingdom	8.72%
Canada	1.91%
Norway	1.31%
France	1.22%
Switzerland	1.18%
Japan	0.79%
Sweden	0.71%
Germany	0.62%
Australia	0.61%
Luxembourg	0.54%
Netherlands	0.49%
Hong Kong	0.36%
South Korea	0.3%
Denmark	0.29%
Individuals	0.26%
Ireland	0.19%
Belgium	0.14%
China	0.13%
Spain	0.12%
Austria	0.09%
Italy	0.08%
Finland	0.06%
Singapore	0.04%
Czech Republic	0.03%
New Zealand	0.03%
Mexico	0.03%
South Africa	0.03%
Taiwan	0.01%
India	0.01%
Saudi Arabia	0.01%
Slovenia	0.01%

Based on 1000 largest holdings

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).

Employees

6,400

Sector

Pharmaceuticals

Calendar

11-02 Earnings release - Q3 2026

More about the company